LoginSignup
ICON logo

ICON

Stock
Stock
ISIN: IE0005711209
Ticker: ICLR
IE0005711209
ICLR

Price

Price

Frequently asked questions

What is ICON's market capitalization?

The market capitalization of ICON is $17.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is ICON's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for ICON is 23.65. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for ICON?

ICON's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $8.994. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for ICON's stock?

Currently, 17 analysts cover ICON's stock, with a consensus target price of $349.63. Analyst ratings provide insights into the stock's expected performance.

What is ICON's revenue over the trailing twelve months?

Over the trailing twelve months, ICON reported a revenue of $8.31B.

What is the EBITDA for ICON?

ICON's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.69B. EBITDA measures the company's overall financial performance.

What is the free cash flow of ICON?

ICON has a free cash flow of $1.23B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of ICON's stock?

The 5-year beta for ICON is 1.22. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does ICON have, and what sector and industry does it belong to?

ICON employs approximately 42,250 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of ICON's shares?

The free float of ICON is 81.97M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $17.57B

5Y beta

 1.22

EPS (TTM)

 $8.994

Free Float

 81.97M

P/E ratio (TTM)

 23.65

Revenue (TTM)

 $8.31B

EBITDA (TTM)

 $1.69B

Free Cashflow (TTM)

 $1.23B

Pricing

1D span
$211.85$214.67
52W span
$183.38$347.72

Analyst Ratings

The price target is $349.63 and the stock is covered by 17 analysts.

Buy

15

Hold

2

Sell

0

Information

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

42,250

Biotechnology & Drugs

Health Care

Identifier

ISIN

IE0005711209

Primary Ticker

ICLR

Knockouts

Join the conversation
Sign upLogin